Agios Pharmaceuticals shares owned by First Trust Advisors
Quarter-by-quarter ownership of Agios Pharmaceuticals (AGIO) shares owned by First Trust Advisors
from 13F filings
Historical chart of First Trust Advisors investment in Agios Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Agios Pharmaceuticals held by First Trust Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Agios Pharmaceuticals by First Trust Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.0M | 74k | 40.14 |
| 2025-06-30 | $1.2M | 36k | 33.26 |
| 2025-03-31 | $1.1M | 37k | 29.30 |
| 2024-12-31 | $3.2M | 97k | 32.86 |
| 2024-09-30 | $4.9M | 111k | 44.43 |
| 2023-09-30 | $44M | 1.8M | 24.75 |
| 2023-06-30 | $61M | 2.2M | 28.32 |
| 2023-03-31 | $42M | 1.8M | 22.97 |
| 2022-12-31 | $46M | 1.6M | 28.08 |
| 2022-09-30 | $56M | 2.0M | 28.28 |
| 2022-06-30 | $38M | 1.7M | 22.17 |
| 2022-03-31 | $47M | 1.6M | 29.11 |
| 2021-12-31 | $42M | 1.3M | 32.87 |
| 2021-09-30 | $51M | 1.1M | 46.15 |
| 2021-06-30 | $83M | 1.5M | 55.11 |
| 2021-03-31 | $81M | 1.6M | 51.64 |
| 2020-12-31 | $79M | 1.8M | 43.33 |
| 2020-09-30 | $63M | 1.8M | 35.00 |
| 2020-06-30 | $85M | 1.6M | 53.48 |
| 2020-03-31 | $45M | 1.3M | 35.48 |
| 2019-12-31 | $73M | 1.5M | 47.75 |
| 2019-09-30 | $42M | 1.3M | 32.40 |
| 2019-06-30 | $89M | 1.8M | 49.88 |
| 2019-03-31 | $120M | 1.8M | 67.44 |
| 2018-12-31 | $62M | 1.4M | 46.11 |
| 2018-09-30 | $90M | 1.2M | 77.12 |
| 2018-06-30 | $62M | 732k | 84.23 |
| 2018-03-31 | $55M | 676k | 81.78 |
| 2017-12-31 | $47M | 814k | 57.17 |
| 2017-09-30 | $43M | 644k | 66.75 |
| 2017-06-30 | $50M | 974k | 51.45 |
| 2017-03-31 | $37M | 640k | 58.40 |
| 2016-12-31 | $23M | 543k | 41.73 |
| 2016-09-30 | $34M | 650k | 52.82 |
| 2016-06-30 | $25M | 591k | 41.90 |
| 2016-03-31 | $25M | 603k | 40.60 |
| 2015-12-31 | $95M | 1.5M | 64.92 |
| 2015-09-30 | $115M | 1.6M | 70.59 |
| 2015-06-30 | $120M | 1.1M | 111.14 |